Technology | April 08, 2013

Terumo Announces U.S. Distribution Agreement For Nonin Equanox 7600 Regional Oximetry System

Terumo CVS will distribute Nonin's Equanox Model 7600 Regional Oximetry System to U.S. adult and pediatric cardiovascular hospitals

Nonin Equanox Model 7600

April 8, 2013 — Terumo Cardiovascular Systems announced it has entered into a multi-year distribution agreement with Nonin Medical Inc. Beginning May 1, 2013, Terumo CVS will distribute Nonin's Equanox Model 7600 Regional Oximetry System to adult and pediatric cardiovascular hospitals in the U.S. Nonin's direct sales force will focus on certain non-cardiovascular applications in those hospitals and applications in all other U.S. hospitals. Terumo CVS manufactures and markets medical devices for the global cardiac surgery market.

The Nonin Equanox Model 7600 Regional Oximetry System is a noninvasive medical monitoring system that continuously detects oxygen saturation status in the brain and tissue beneath the sensor during surgical procedures and in intensive care environments such as pediatric and neonatal intensive care units. The system allows anesthesiologists, perfusionists, cardiovascular surgeons and other clinicians to quickly react to reverse tissue ischemia events before they become critical. 

"Unlike other regional oximetry systems that may only indicate whether oxygen levels are increasing or decreasing, Equanox system's patented technology provides real-time absolute accuracy of actual physiologic conditions on neonatal to adult patients, regardless of age, weight or skin color,” said Eric Sklar, vice president of business development for Terumo CVS.

About 500,000 cardiovascular surgical procedures are performed annually in the U.S. Regional oximetry-monitored procedures typically allow for early indication of oxygen desaturation that could lead to stroke, neurocognitive decline and other neurological or major organ injuries resulting from inadequate oxygen saturation. Regional oximetry solutions have been shown to reduce the cost of post-operative care and improve patient outcomes.

Features of the Equanox Advance Model 7600 Regional Oximetry System include:

  • Cerebral and Somatic Monitoring – Up to four channels displayed on one screen for monitoring oxygen saturation in the brain and somatic sites on the body.
  • Patented Dual-Light Emitters and Dual Detectors With Four Wavelength Accuracy  The first and only device that utilizes a dual-light emitting and dual-detecting sensor architecture, which has been shown to more effectively target the cerebral cortex, eliminating surface artifacts that interfere with measurement accuracy.
  • Absolute Accuracy – Assures accurate measure of tissue saturation at a point in time, not just relative or trending accuracy of changes.
  • Consistency and Reliability – Rapid, reliable response to change without signal instability and interruptions from electrical and ambient light interference.
  • Portability and Connectivity – Lightweight, durable monitor with long battery life and pole-mounting capability for continually monitoring patients during intra-hospital transport. Data output available via Bluetooth wireless technology or RS232 connection.

For more information: www.noninequanox.com, www.terumo-cvs.com

Related Content

Fysicon Receives FDA Approval for QMAPP Hemodynamic Monitoring System
Technology | Hemodynamic Monitoring Systems| September 18, 2017
Fysicon announced that it has been granted 510(k) clearance by the U.S. Food and Drug Administration (FDA) for its...
Wearable monitors create patient generated health data, PGHD, that can help prevent acute care episodes in heart failure.

Wearable monitoring devices may offer a new tool to help prevent acute care episodes in heart failure.

Feature | Heart Failure| July 25, 2017 | Lola Koktysh
Despite their best efforts, many patients tend to develop heart failure after an acute event (e.g., a heart attack or
Left Atrial Pressure Monitor Offers New Hope for Heart Failure Patients
News | Heart Failure| July 14, 2017
A review appearing in the July 18 issue of the Journal of the American College of Cardiology (JACC) discusses current...
monitoring a heart failure patient's chest fluid buildup with remote monitoring using the SensiVest

A heart failure patient wearing the SensiVest remote monitoring system for a two-minute a day assessment. 

News | Heart Failure| July 13, 2017
July 13, 2017 — About 5.7 million adults in the U.S.
Sponsored Content | Videos | Heart Failure| July 13, 2017
William Abraham, M.D., director of the Division of Cardiovascular Medicine at The Ohio State University Wexner Medica
Ohio State Investigating High-Tech Vest for At-Home Heart Failure Management
News | Heart Failure| June 28, 2017
Doctors at The Ohio State University Richard M. Ross Heart Hospital are testing a high-tech vest that measures fluid...
First Canadian Patient Implanted With CardioMEMS Heart Failure Sensor
News | Heart Failure| June 23, 2017
In a Canadian first, a medical team has implanted the wireless CardioMEMS HF device inside a heart failure patient. The...
Northwell Health Partners With Peerbridge Health on Remote Patient Monitoring
News | Wearable Sensors| June 01, 2017
Northwell Health recently announced a new partnership agreement with Peerbridge Health Inc., to explore the future of...
Sponsored Content | Videos | EP Lab| May 26, 2017
DAIC Editor Dave Fornell takes a tour of some of the most innovative new electrophysiology (EP) technology at the 201
Consumers Warned About Accuracy of Heart Rate Apps in New Study
News | Mobile Devices| May 22, 2017
May 22, 2017 — Consumers are being warned about the accuracy of heart rate apps after a study found huge variability
Overlay Init